Showing 65,781 - 65,800 results of 70,031 for search '(( 01 ((1 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 1.68s Refine Results
  1. 65781
  2. 65782
  3. 65783
  4. 65784
  5. 65785
  6. 65786
  7. 65787
  8. 65788
  9. 65789
  10. 65790

    Protein interaction, transcription and phenotypic profiling reveal an overlap in regulatory influence of XC_3703 and XC_2801. by Shi-qi An (5661025)

    Published 2014
    “…(D) Biofilm and cell adhesion of the <i>XC_2801</i> mutant to a glass surface was decreased compared to wild-type strain 8004. …”
  11. 65791
  12. 65792
  13. 65793
  14. 65794
  15. 65795

    The MTT assay demonstrated that miR-21 can enhance cell growth and proliferation. by Shuyan Sheng (12098234)

    Published 2022
    “…Mock, negative control; Lipo: Liposome control. **, <i>P</i><0.01; ***, <i>P</i><0.001; ****, <i>P</i><0.0001. ns, nonsignificant.…”
  16. 65796

    NAC treatment or AON overexpression reversed the detrimental effects of PM exposure on BMSCs. by Yuqi Cui (736228)

    Published 2015
    “…(B) Decreased level of P-Akt was significantly increased by NAC treatment or AON in the mice exposed with PM. * WT+ PM or WT+ PM+NAC vs WT+PBS, P<0.01, n = 8; ** TG Ctrl+ PM vs TG+ PM, P<0.01, n = 8. …”
  17. 65797

    Real-time PCR analysis of selected genes. by PLOS ONE (2189197)

    Published 2014
    “…<sup>*</sup><i>P</i>< 0.05, <sup>**</sup><i>P</i>< 0.01.</p>…”
  18. 65798
  19. 65799

    Table2_Network Meta-Analysis of Different Intravenous Glucocorticoid Regimes for the Treatment of Graves’ Orbitopathy.DOCX by Jun Jia (112173)

    Published 2022
    “…Network meta-analysis suggested that the weekly intravenous GC regime (WR) [response: odds ratio (OR), 4.27; 95% creditable interval (CrI); 1.82 to 11.02; clinical activity score change (CASC): standard mean difference (SMD), −0.59; 95% CrI; −1.19 to −0.03) and monthly intravenous regime (MR) (response: OR, 6.32; 95% CrI; 1.25 to 34.96; CASC: SMD, −1.17; 95% CrI; −2.32 to −0.01) were superior to the oral GC (OGC) regime in response and CASC. …”
  20. 65800